Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Takeshita H, Yoshida R, Inoue J, Ishikawa K, Shinohara K, Hirayama M, Oyama T, Kubo R, Yamana K, Nagao Y, Gohara S, Sakata J, Nakashima H, Matsuoka Y, Nakamoto M, Hirayama M, Kawahara K, Takahashi N, Hirosue A, Kuwahara Y, Fukumoto M, Toya R, Murakami R, Nakayama H. Takeshita H, et al. Among authors: hirosue a. Lab Invest. 2023 May;103(5):100060. doi: 10.1016/j.labinv.2022.100060. Epub 2023 Jan 10. Lab Invest. 2023. PMID: 36801643 Free article.
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma.
Gohara S, Shinohara K, Yoshida R, Kariya R, Tazawa H, Hashimoto M, Inoue J, Kubo R, Nakashima H, Arita H, Kawaguchi S, Yamana K, Nagao Y, Iwamoto A, Sakata J, Matsuoka Y, Takeshita H, Hirayama M, Kawahara K, Nagata M, Hirosue A, Kuwahara Y, Fukumoto M, Okada S, Urata Y, Fujiwara T, Nakayama H. Gohara S, et al. Among authors: hirosue a. Mol Ther Oncolytics. 2022 Oct 8;27:141-156. doi: 10.1016/j.omto.2022.10.001. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36381653 Free PMC article.
The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation.
Matsuoka Y, Yoshida R, Kawahara K, Sakata J, Arita H, Nkashima H, Takahashi N, Hirayama M, Nagata M, Hirosue A, Kuwahara Y, Fukumoto M, Toya R, Murakami R, Nakayama H. Matsuoka Y, et al. Among authors: hirosue a. Lab Invest. 2022 Aug;102(8):896-907. doi: 10.1038/s41374-022-00776-w. Epub 2022 Apr 12. Lab Invest. 2022. PMID: 35414650 Free PMC article.
Factors Affecting Human Damage in Heavy Rains and Typhoon Disasters.
Naito H, Sueta D, Hanatani S, Ikeda H, Hirosue A, Senokuchi T, Araki E, Tsujita K, Nakayama H, Kasaoka S. Naito H, et al. Among authors: hirosue a. Tohoku J Exp Med. 2022 Feb;256(2):175-185. doi: 10.1620/tjem.256.175. Tohoku J Exp Med. 2022. PMID: 35236809 Free article.
Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
Kawaguchi S, Kawahara K, Fujiwara Y, Ohnishi K, Pan C, Yano H, Hirosue A, Nagata M, Hirayama M, Sakata J, Nakashima H, Arita H, Yamana K, Gohara S, Nagao Y, Maeshiro M, Iwamoto A, Hirayama M, Yoshida R, Komohara Y, Nakayama H. Kawaguchi S, et al. Among authors: hirosue a. Cancer Immunol Immunother. 2022 Sep;71(9):2127-2139. doi: 10.1007/s00262-022-03149-w. Epub 2022 Jan 19. Cancer Immunol Immunother. 2022. PMID: 35044489 Free PMC article.
Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR-503-3p-BAK axis.
Yamana K, Inoue J, Yoshida R, Sakata J, Nakashima H, Arita H, Kawaguchi S, Gohara S, Nagao Y, Takeshita H, Maeshiro M, Liu R, Matsuoka Y, Hirayama M, Kawahara K, Nagata M, Hirosue A, Toya R, Murakami R, Kuwahara Y, Fukumoto M, Nakayama H. Yamana K, et al. Among authors: hirosue a. J Extracell Vesicles. 2021 Dec;10(14):e12169. doi: 10.1002/jev2.12169. J Extracell Vesicles. 2021. PMID: 34894384 Free PMC article.
miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma.
Kawahara K, Nagata M, Yoshida R, Hirosue A, Tanaka T, Matsuoka Y, Arita H, Nakashima H, Sakata J, Yamana K, Kawaguchi S, Gohara S, Nagao Y, Hirayama M, Takahashi N, Hirayama M, Nakayama H. Kawahara K, et al. Among authors: hirosue a. Biochem Biophys Rep. 2021 Sep 21;28:101114. doi: 10.1016/j.bbrep.2021.101114. eCollection 2021 Dec. Biochem Biophys Rep. 2021. PMID: 34589618 Free PMC article.
Can MRI-derived depth of invasion predict nodal recurrence in oral tongue cancer?
Minamitake A, Murakami R, Sakamoto F, Yoshida R, Sakata J, Hirosue A, Kawahara K, Yamana K, Nakayama H, Toya R, Shiraishi S. Minamitake A, et al. Among authors: hirosue a. Oral Radiol. 2021 Oct;37(4):641-646. doi: 10.1007/s11282-020-00505-3. Epub 2021 Jan 19. Oral Radiol. 2021. PMID: 33469800
39 results